Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial

S Costi, L Soleimani, A Glasgow, J Brallier… - …, 2019 - nature.com
The N-methyl-d-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but
transient antidepressant effects in patients with treatment resistant unipolar depression …
被引用次数：45 相关文章
[HTML] nih.gov

[HTML][HTML] Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial

S Costi, L Soleimani, A Glasgow, J Brallier… - …, 2019 - ncbi.nlm.nih.gov
The N-methyl-d-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but
transient antidepressant effects in patients with treatment resistant unipolar depression …

Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial

S Costi, L Soleimani, A Glasgow, J Brallier, J Spivack… - 2019 - pubmed.ncbi.nlm.nih.gov
The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but
transient antidepressant effects in patients with treatment resistant unipolar depression …

Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial.

S Costi, L Soleimani, A Glasgow, J Brallier… - … : Official Publication of …, 2019 - europepmc.org
The N-methyl-d-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but
transient antidepressant effects in patients with treatment resistant unipolar depression …

Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial

S Costi, L Soleimani, A Glasgow… - …, 2019 - einstein.elsevierpure.com
The N-methyl-d-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but
transient antidepressant effects in patients with treatment resistant unipolar depression …

Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial.

S Costi, L Soleimani, A Glasgow, J Brallier… - … : Official Publication of …, 2019 - europepmc.org
The N-methyl-d-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but
transient antidepressant effects in patients with treatment resistant unipolar depression …